Press Release-IV-08-042, NRC Staff Proposes $3,250 Fine for Security Violations at Glaxosmithkline Biologicals: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 19: Line 19:


=Text=
=Text=
{{#Wiki_filter:No. IV-08-042
{{#Wiki_filter:NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs Region IV 612 E. Lamar Blvd., Suite 400 Arlington, TX 76011-4125 Telephone: (817) 860-8128 No. IV-08-042                                                                              December 10, 2008 Contact: Victor Dricks                                                                    E-Mail: opa4@nrc.gov Phone: (817) 860-8128 NRC STAFF PROPOSES $3,250 FINE FOR SECURITY VIOLATIONS AT GLAXOSMITHKLINE BIOLOGICALS The Nuclear Regulatory Commission staff has proposed a $3,250 fine against GlaxoSmithKline Biologicals, in Hamilton, Mont., for failing to institute certain security measures.
 
The company holds an NRC license authorizing it to possess and use radioactive materials for pharmaceutical research.
Contact:  Victor Dricks
In November 2005, the NRC issued an Order to GlaxoSmithKline and similar firms, imposing new additional security requirements for the storage and protection of radioactive materials. An inspection conducted by the NRC staff in August identified two violations of NRC security requirements associated with that Order.
 
The $3,250 fine is being proposed because the company failed to take the necessary security precautions intended to properly safeguard radioactive materials in their possession and for failing to immediately correct the violations identified by the NRC inspector, said NRC Region IV Administrator Elmo E. Collins. Ultimately, the company transferred its radioactive material to another authorized user and is no longer required to follow those NRC security requirements.
Phone: (817) 860-8128  
The company has 30 days to pay the fine or protest it. If the fine is protested and subsequently imposed by the NRC staff, the company may request a hearing.
 
December 10, 2008                                       E-Mail: opa4@nrc.gov NRC STAFF PROPOSES $3,250 FINE FOR SECURITY VIOLATIONS AT GLAXOSMITHKLINE BIOLOGICALS The Nuclear Regulatory Commission staff has proposed a $3,250 fine against GlaxoSmithKline Biologicals, in Hamilton, Mont., for failing to institute certain security measures.  
 
The company holds an NRC license authorizing it to possess and use radioactive materials for pharmaceutical research.  
 
In November 2005, the NRC issued an Order to GlaxoSmithKline and similar firms, imposing new additional security requirements for the storage and protection of radioactive materials. An inspection conducted by the NRC staff in August id entified two violations of NRC security requirements associated with that Order.  
 
"The $3,250 fine is being proposed because the company failed to take the necessary security precautions intended to properly safeguard radioactive materials in their possession and for failing to immediately correct the violations identified by the NRC inspector," said NRC Region IV Administrator Elmo E. Collins. "Ultimately, the company transferred its radioactive material to another authorized user and is no longer required to follow those NRC security requirements."
 
The company has 30 days to pay the fine or protest it. If the fine is protested and subsequently imposed by the NRC staff, the company may request a hearing.  
 
Because the violations involved security measures at the facility, the details of the requirements and the violations are not being publicly disclosed.
Because the violations involved security measures at the facility, the details of the requirements and the violations are not being publicly disclosed.
        ###
                                                        ###
NRC news releases are available through a free list serve subscription at the following Web address: http://www.nrc.gov/public-involve/listserver.html . The NRC homepage at www.nrc.gov also offers a SUBSCRIBE link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.
NRC news releases are available through a free list serve subscription at the following Web address:
NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs  Region IV 612 E. Lamar Blvd., Suite 400 Arlington, TX  76011-4125 Telephone: (817) 860-8128}}
http://www.nrc.gov/public-involve/listserver.html . The NRC homepage at www.nrc.gov also offers a SUBSCRIBE link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.}}

Revision as of 11:31, 14 November 2019

Press Release-IV-08-042: NRC Staff Proposes $3,250 Fine for Security Violations at Glaxosmithkline Biologicals
ML083450413
Person / Time
Issue date: 12/10/2008
From:
Office of Public Affairs Region IV
To:
Category:Press Release
References
Press Release-IV-08-042
Download: ML083450413 (1)
v • d • e


Text

NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs Region IV 612 E. Lamar Blvd., Suite 400 Arlington, TX 76011-4125 Telephone: (817) 860-8128 No. IV-08-042 December 10, 2008 Contact: Victor Dricks E-Mail: opa4@nrc.gov Phone: (817) 860-8128 NRC STAFF PROPOSES $3,250 FINE FOR SECURITY VIOLATIONS AT GLAXOSMITHKLINE BIOLOGICALS The Nuclear Regulatory Commission staff has proposed a $3,250 fine against GlaxoSmithKline Biologicals, in Hamilton, Mont., for failing to institute certain security measures.

The company holds an NRC license authorizing it to possess and use radioactive materials for pharmaceutical research.

In November 2005, the NRC issued an Order to GlaxoSmithKline and similar firms, imposing new additional security requirements for the storage and protection of radioactive materials. An inspection conducted by the NRC staff in August identified two violations of NRC security requirements associated with that Order.

The $3,250 fine is being proposed because the company failed to take the necessary security precautions intended to properly safeguard radioactive materials in their possession and for failing to immediately correct the violations identified by the NRC inspector, said NRC Region IV Administrator Elmo E. Collins. Ultimately, the company transferred its radioactive material to another authorized user and is no longer required to follow those NRC security requirements.

The company has 30 days to pay the fine or protest it. If the fine is protested and subsequently imposed by the NRC staff, the company may request a hearing.

Because the violations involved security measures at the facility, the details of the requirements and the violations are not being publicly disclosed.

NRC news releases are available through a free list serve subscription at the following Web address:

http://www.nrc.gov/public-involve/listserver.html . The NRC homepage at www.nrc.gov also offers a SUBSCRIBE link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.

Retrieved from "https://kanterella.com/w/index.php?title=Press_Release-IV-08-042,_NRC_Staff_Proposes_$3,250_Fine_for_Security_Violations_at_Glaxosmithkline_Biologicals&oldid=2150729"